Deep Tech Startups

Almawave develops artificial intelligence and natural language processing technology, including a multilingual, multimodal large language model family and a cognitive platform for AI adoption. It offers data analytics, location intelligence, and semantic solutions for enterprises across sectors such as water, gas distribution, and customer communication.

1 investor

Almure builds confidential computing security infrastructure that combines encryption-key-level safety with AI execution, aiming to let AI agents work with highly sensitive data without compromising security or privacy. Its first application targets work-hours/project tracking, capturing detailed work logs automatically without manual input or employee surveillance.

1 investor

Alp Bio operates a platform that combines human tonsil organoid technology with protein AI models to assess and reduce immunogenicity (anti-drug antibody) risk in therapeutic antibodies before clinical development. It serves biologics developers with in-silico ADA screening, ex vivo tonsil organoid assays, and generative redesign of antibody sequences.

1 investor

Alpenglow Biosciences develops AI-enabled 3D tissue imaging and spatial profiling platforms for researchers and clinical teams in pathology and diagnostics. The company's patented light-sheet microscopy technology provides volumetric tissue data for analysis and clinical discovery applications.

1 investor

Alpha MOS provides sensory analysis and measurement solutions for the food and beverage, pharmaceutical, and industrial sectors. The company serves large corporations and manufacturers seeking to improve product quality and compliance through sensory technologies.

1 investor

Alpha Ring develops micro-fusion technology using proton-boron fusion reactions to generate clean energy for sectors including energy, healthcare, education, and heavy industry. The company designs compact, decentralized systems intended to accelerate commercial fusion deployment globally.

1 investor

A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.

1 investor

EMBL's European Bioinformatics Institute (EMBL-EBI) manages open biological data resources and provides tools for browsing data, performing analyses, and sharing research results. It also offers bioinformatics training, research programmes, and industry partnerships, serving scientists across Europe as part of the intergovernmental EMBL organisation.

1 investor

AlphaSTAR is an aerospace technology company led by experienced scientists and executives.

1 investor

AQT develops quantum computers and quantum algorithms to solve complex problems across industries including aerospace, chemistry, materials science, and finance. The company designs compact, rack-mounted quantum systems optimized for integration into existing high-performance computing infrastructure.

1 investor

Alpine Optoelectronics designs and develops photonic products for optical networks, focusing on silicon photonics, PAM4, and coherent technologies.

1 investor

Alpine Space is a venture capital firm that invests in early-stage startups in the space and space-enabled industries, backing teams building scalable technologies with commercial potential in existing markets.

1 investor

AlSentis develops no-tuning touch input technology and software for original equipment manufacturers requiring precision and reliability in challenging environments. The company provides intelligent touch systems designed for high performance and ease of integration across diverse industrial and commercial applications.

1 investor

ALTDATA builds physics-anchored digital twins and privacy-safe synthetic data to address data scarcity for research-intensive teams in biotech, healthcare, and space. The Adelaide-based company serves biomedical researchers and space agencies who face barriers to accessing or generating experimental data.

1 investor

Altered Carbon builds a chemical-sensing platform based on proprietary graphene nanomaterials that lets machines detect and interpret airborne chemical signals at ultra-low power. The technology serves applications across the built environment, healthcare, food and agriculture, security and defence, industrial infrastructure, and robotics/autonomous systems.

1 investor

AlterEgo builds a non-invasive, wearable neural interface that uses "Silent Sense" technology to let users communicate with AI through silent, intentional speech without typing, tapping, or speaking aloud. Developed at MIT, the device targets hands-free, screen-free human-computer interaction.

1 investor

Altitud 100K is a Chilean applied-science company offering AI, automation, engineering, and STEM training services, along with R&D in oncology, medical engineering, and aerospace engineering (CubeSats). It serves businesses seeking AI adoption and process automation, schools and universities wanting STEM programs, and health and research institutions.

1 investor

Altitude Accelerator is an entrepreneurial support and acceleration program offering administrative guidance, mentorship, and access to resources for emerging companies. Based in Peel Region, Ontario, it works with industry, educational institutions, and government stakeholders to develop innovation capacity across multiple sectors.

1 investor

Altratech develops point-of-care diagnostic technology for quantitative HIV viral load testing in low- and middle-income countries. The company creates affordable and accessible medical devices for resource-limited healthcare settings.

1 investor

Altris develops Prussian White sodium-ion cathode-active materials for use in automotive, energy storage, and industrial applications across Europe. The company commercializes electrochemistry research from Uppsala University to establish a domestic European standard for sodium-ion batteries.

1 investor

ALUVATION provides intelligent heat treatment services for aluminium components through both a dedicated technology center offering custom process development and product carriers, and a mobile, on-demand rental system called System ALUVATION® that includes remote monitoring and data management.

1 investor

Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time. The company serves patients at risk of stroke and the healthcare system, focusing on improving outcomes through rapid detection and treatment initiation.

1 investor

AlveoGene develops respiratory gene therapies, led by executives and academic researchers from the UK Respiratory Gene Therapy Consortium.

1 investor

Alyssum is a biotechnology company developing novel therapeutic drugs, with expertise in protein engineering, oncology, and clinical development. Its leadership includes veterans of multiple FDA-approved medicines and accelerated approvals.

1 investor